Aragen Life Sciences
PrivateLast Round
Private Equity
Jan 13, 2025
Est. Valuation
$1.4B
Total Funding Raised
$100.3M
Company Overview
Aragen Life Sciences operates in Healthcare & Life Sciences and is based in Hyderabad. Its latest recorded funding round was a Private Equity round in January 2025.
Aragen Life Sciences is a contract research, development, and manufacturing organization (CRDMO) that provides integrated solutions for drug discovery, development, and manufacturing to the global life sciences industry.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Aragen Life Sciences Comparables
Compare Aragen Life Sciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Anthem Biosciences Ltd | 93% | |
| Sai Life Sciences | 91% | |
| Recipharm | 86% |
For institutional investors. Book with your work email.
Aragen Life Sciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Private Equity | Jan 13, 2025 | ||||
| Secondary | Aug 12, 2023 | ||||
| Secondary | May 19, 2021 | ||||
| Secondary | Dec 2, 2015 | ||||
| Private Equity | Nov 27, 2007 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Aragen Life Sciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| ChrysCapital | Secondary |
| Peak XV Partners | Private Equity |
| Goldman Sachs (Asia) LLC | Secondary |
| Avendus Capital | Private Equity, Secondary |
| Sequoia Capital | Private Equity |
| Quadria Capital | Private Equity |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 13, 2025
Secondary round with $1.4B valuation led by Avendus Future Leaders Fund III.
- Jan 13, 2025
$75M round led by Quadria Capital
For institutional investors. Book with your work email.
Aragen Life Sciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Aragen Life Sciences's valuation, stock price, and market status.
Is Aragen Life Sciences a public or private company?
Aragen Life Sciences is a private company.
What is the current stock price of Aragen Life Sciences?
Aragen Life Sciences is a private company, so its shares have no public market price. Caplight tracks Aragen Life Sciences's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Aragen Life Sciences worth (valuation)?
Aragen Life Sciences's valuation is estimated at $1.4B based on funding round data.
Can I buy Aragen Life Sciences stock?
Aragen Life Sciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Aragen Life Sciences's last funding round?
Aragen Life Sciences's most recent funding round was Private Equity on January 13, 2025.
Who are the main investors in Aragen Life Sciences?
Key investors in Aragen Life Sciences include ChrysCapital, Goldman Sachs (Asia) LLC, Avendus Capital, Sequoia Capital, Quadria Capital.
Will Aragen Life Sciences IPO soon?
No public IPO plans have been announced for Aragen Life Sciences.
How can I track Aragen Life Sciences secondary market activity?
Caplight tracks bids, offers, and trades in Aragen Life Sciences's shares on secondary markets.